Multicentric prognostic observational study on biomarker profile in immunotherapy-naïve patients with highly active generalized myasthenia gravis (PROGNO-MG): a study protocol.
Kohle F, Konen F F, Grittner U, Schulze D, Glaubitz S, Nelke C, Schroeter CB, Huntemann N, Trillenberg P, Großkreutz J, et al.
Neurol Res Pract. 2026 May 12; 8(1). PMID: 42121215.Abstract
